Colchicine (Colcrys®)

DRUG2 trials

Sponsors

Regeneron Pharmaceuticals, Ayesha Ather

Conditions

ColchicineColchicine Adverse ReactionInflammation in Cardiac SurgeryInflammatory MarkersIntercritical GoutPost Operative Atrial Fibrillation

Phase 4

Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol

CompletedNCT01451645

Regeneron PharmaceuticalsIntercritical Gout

Start: 2011-10-31End: 2012-09-30Updated: 2014-05-12

Colchicine's Effect on Inflammatory Markers

RecruitingNCT07287345

Ayesha AtherColchicine, Colchicine Adverse Reaction, Inflammation in Cardiac Surgery +2

Start: 2026-01-16End: 2026-12-30Target: 24Updated: 2026-06-25